Free Trial

Best Stocks Under $3 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

atai Life Sciences stock logo

1. atai Life Sciences NASDAQ:ATAI

$2.72 +0.10 (+3.82%)
Closing price 04:00 PM Eastern
Extended Trading
$2.72 -0.01 (-0.18%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$544.92 million
P/E Ratio
-2.99
Consensus Rating
Strong Buy
Consensus Price Target
$9.00 (+230.9% Upside)
Volume
2.92 million shares
Average Volume
3.06 million shares
TuHURA Biosciences stock logo

2. TuHURA Biosciences NASDAQ:HURA

$2.33 +0.03 (+1.30%)
Closing price 04:00 PM Eastern
Extended Trading
$2.36 +0.03 (+1.46%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$101.77 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+443.6% Upside)
Volume
160,172 shares
Average Volume
236,947 shares
Today's Range
$2.27
$2.38
zSpace stock logo

3. zSpace NASDAQ:ZSPC

$2.84 +0.07 (+2.53%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$64.98 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+428.2% Upside)
Volume
97,525 shares
Average Volume
64,282 shares
Today's Range
$2.64
$3.00
OS Therapies stock logo

4. OS Therapies NYSE:OSTX

$1.56 -0.14 (-8.24%)
Closing price 04:00 PM Eastern
Extended Trading
$1.57 +0.01 (+0.90%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$43.83 million
P/E Ratio
-1.81
Consensus Rating
Buy
Consensus Price Target
$18.00 (+1,053.8% Upside)
Volume
721,608 shares
Average Volume
784,432 shares
Western Copper & Gold stock logo

5. Western Copper & Gold NYSE:WRN

$1.33 0.00 (0.00%)
As of 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$266.31 million
P/E Ratio
-66.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+200.8% Upside)
Volume
231,765 shares
Average Volume
375,304 shares
OnKure Therapeutics stock logo

6. OnKure Therapeutics NASDAQ:OKUR

$2.50 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.52 +0.02 (+1.00%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$33.78 million
P/E Ratio
-0.48
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,193.3% Upside)
Volume
41,380 shares
Average Volume
111,623 shares
GeoVax Labs stock logo

7. GeoVax Labs NASDAQ:GOVX

$0.69 +0.01 (+1.39%)
As of 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$10.91 million
P/E Ratio
-0.19
Consensus Rating
Buy
Consensus Price Target
$11.10 (+1,520.2% Upside)
Volume
1.17 million shares
Average Volume
948,225 shares
Reviva Pharmaceuticals stock logo

8. Reviva Pharmaceuticals NASDAQ:RVPH

$0.43 +0.04 (+9.74%)
Closing price 04:00 PM Eastern
Extended Trading
$0.43 +0.00 (+0.86%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$20.61 million
P/E Ratio
-0.54
Consensus Rating
Buy
Consensus Price Target
$9.00 (+1,996.4% Upside)
Volume
3.88 million shares
Average Volume
1.49 million shares
Quince Therapeutics stock logo

9. Quince Therapeutics NASDAQ:QNCX

$1.78 -0.04 (-2.20%)
Closing price 04:00 PM Eastern
Extended Trading
$1.82 +0.04 (+2.25%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$80.94 million
P/E Ratio
-1.28
Consensus Rating
Buy
Consensus Price Target
$8.00 (+349.4% Upside)
Volume
310,688 shares
Average Volume
243,906 shares
Denison Mine stock logo

10. Denison Mine NYSEAMERICAN:DNN

$1.86 +0.08 (+4.49%)
Closing price 04:10 PM Eastern
Extended Trading
$1.84 -0.02 (-0.81%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.67 billion
P/E Ratio
-23.25
Consensus Rating
Buy
Consensus Price Target
$3.00 (+61.3% Upside)
Volume
67.52 million shares
Average Volume
80.81 million shares
Immunic stock logo

11. Immunic NASDAQ:IMUX

$0.84 +0.01 (+1.19%)
Closing price 04:00 PM Eastern
Extended Trading
$0.83 -0.01 (-1.07%)
As of 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$80.49 million
P/E Ratio
-0.68
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,281.0% Upside)
Volume
367,687 shares
Average Volume
1.25 million shares
Rezolve AI stock logo

12. Rezolve AI NASDAQ:RZLV

$2.45 -0.09 (-3.54%)
Closing price 04:00 PM Eastern
Extended Trading
$2.46 +0.00 (+0.20%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$510.24 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+144.9% Upside)
Volume
4.43 million shares
Average Volume
6.28 million shares
Today's Range
$2.42
$2.56
United States Antimony stock logo

13. United States Antimony NYSE:UAMY

$2.99 +0.27 (+9.93%)
Closing price 04:00 PM Eastern
Extended Trading
$3.08 +0.09 (+2.84%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$356.11 million
P/E Ratio
-74.75
Consensus Rating
Buy
Consensus Price Target
$3.38 (+12.9% Upside)
Volume
9.16 million shares
Average Volume
3.49 million shares
ImmunityBio stock logo

14. ImmunityBio NASDAQ:IBRX

$2.90 +0.09 (+3.20%)
Closing price 04:00 PM Eastern
Extended Trading
$2.88 -0.02 (-0.52%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.56 billion
P/E Ratio
-5.00
Consensus Rating
Buy
Consensus Price Target
$12.25 (+322.4% Upside)
Volume
5.67 million shares
Average Volume
7.65 million shares
Lucid Diagnostics stock logo

15. Lucid Diagnostics NASDAQ:LUCD

$1.17 +0.03 (+2.63%)
Closing price 04:00 PM Eastern
Extended Trading
$1.19 +0.02 (+1.37%)
As of 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$126.58 million
P/E Ratio
-0.87
Consensus Rating
Buy
Consensus Price Target
$3.55 (+203.4% Upside)
Volume
1.19 million shares
Average Volume
1.03 million shares
Stardust Power stock logo

16. Stardust Power NASDAQ:SDST

$0.47 +0.22 (+88.29%)
Closing price 04:00 PM Eastern
Extended Trading
$0.48 +0.00 (+0.74%)
As of 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$28.55 million
P/E Ratio
-0.64
Consensus Rating
Buy
Consensus Price Target
$5.11 (+977.4% Upside)
Volume
383.60 million shares
Average Volume
4.54 million shares
Ovid Therapeutics stock logo

17. Ovid Therapeutics NASDAQ:OVID

$0.40 -0.01 (-2.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.40 +0.00 (+0.03%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$28.22 million
P/E Ratio
-1.13
Consensus Rating
Buy
Consensus Price Target
$3.13 (+687.4% Upside)
Volume
443,469 shares
Average Volume
654,611 shares
Ceragon Networks stock logo

18. Ceragon Networks NASDAQ:CRNT

$2.43 -0.03 (-1.22%)
Closing price 04:00 PM Eastern
Extended Trading
$2.46 +0.03 (+1.23%)
As of 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon Networks

Market Capitalization
$216.10 million
P/E Ratio
9.35
Consensus Rating
Buy
Consensus Price Target
$6.00 (+146.9% Upside)
Volume
820,920 shares
Average Volume
1.39 million shares
FibroBiologics stock logo

19. FibroBiologics NASDAQ:FBLG

$0.64 +0.01 (+1.70%)
Closing price 04:00 PM Eastern
Extended Trading
$0.63 -0.01 (-1.09%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$25.40 million
P/E Ratio
-3.05
Consensus Rating
Buy
Consensus Price Target
$13.00 (+1,931.3% Upside)
Volume
407,563 shares
Average Volume
311,204 shares
Mereo BioPharma Group stock logo

20. Mereo BioPharma Group NASDAQ:MREO

$1.72 +0.11 (+6.83%)
Closing price 04:00 PM Eastern
Extended Trading
$1.70 -0.02 (-1.45%)
As of 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$273.48 million
P/E Ratio
-24.57
Consensus Rating
Buy
Consensus Price Target
$7.20 (+318.6% Upside)
Volume
5.68 million shares
Average Volume
1.74 million shares
Nuvation Bio stock logo

21. Nuvation Bio NYSE:NUVB

$2.15 -0.05 (-2.09%)
Closing price 03:59 PM Eastern
Extended Trading
$2.14 -0.01 (-0.42%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$732.92 million
P/E Ratio
-0.92
Consensus Rating
Buy
Consensus Price Target
$7.17 (+232.7% Upside)
Volume
4.55 million shares
Average Volume
4.18 million shares
HIVE Digital Technologies stock logo

22. HIVE Digital Technologies NASDAQ:HIVE

$2.30 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.32 +0.02 (+0.65%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$492.90 million
P/E Ratio
-6.39
Consensus Rating
Buy
Consensus Price Target
$6.57 (+185.7% Upside)
Volume
34.44 million shares
Average Volume
13.08 million shares
Biomea Fusion stock logo

23. Biomea Fusion NASDAQ:BMEA

$1.94 -0.06 (-3.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.95 +0.01 (+0.52%)
As of 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea Fusion

Market Capitalization
$72.89 million
P/E Ratio
-0.55
Consensus Rating
Buy
Consensus Price Target
$21.40 (+1,003.1% Upside)
Volume
747,457 shares
Average Volume
1.50 million shares
Context Therapeutics stock logo

24. Context Therapeutics NASDAQ:CNTX

$0.73 +0.06 (+9.27%)
Closing price 04:00 PM Eastern
Extended Trading
$0.75 +0.02 (+2.16%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$65.68 million
P/E Ratio
-2.36
Consensus Rating
Buy
Consensus Price Target
$5.50 (+651.2% Upside)
Volume
514,870 shares
Average Volume
201,752 shares
Gain Therapeutics stock logo

25. Gain Therapeutics NASDAQ:GANX

$1.86 +0.13 (+7.51%)
Closing price 04:00 PM Eastern
Extended Trading
$1.86 -0.01 (-0.27%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain Therapeutics

Market Capitalization
$55.71 million
P/E Ratio
-2.16
Consensus Rating
Buy
Consensus Price Target
$8.20 (+340.9% Upside)
Volume
389,921 shares
Average Volume
264,531 shares